# Prospective Phase II Randomized Trial of Postoperative Adjuvant Chemotherapy in Patients With High Risk Colon Cancer

> **NCT00201331** · PHASE2 · UNKNOWN · sponsor: **National Health Research Institutes, Taiwan** · enrollment: 162 (—)

## Conditions studied

- Colonic Diseases
- Adenocarcinoma

## Interventions

- **DRUG:** leucovorin+5-FU

## Key facts

- **NCT ID:** NCT00201331
- **Lead sponsor:** National Health Research Institutes, Taiwan
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2002-04
- **Primary completion:** —
- **Final completion:** 2012-10
- **Target enrollment:** 162 (—)
- **Last updated:** 2005-12-16

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00201331

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00201331, "Prospective Phase II Randomized Trial of Postoperative Adjuvant Chemotherapy in Patients With High Risk Colon Cancer". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00201331. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*